ASX-listed digital health firm ResApp Health has announced that its pilot clinical trial for a smartphone-based COVID-19 screening test has achieved positive results.
The new diagnostic app, which uses machine learning to analyse the sound of a patient's cough, was reported to correctly detect COVID-19 in 92% of participants with the infection during the trial. With a 92% sensitivity, it exceeds...